We are live on ! Find out more
WANY

Wealthspire Advisors (New York) Portfolio holdings

AUM $12.7B
1-Year Est. Return 17.31%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+17.31%
3 Year Est. Return
+47.87%
5 Year Est. Return
+46.91%
10 Year Est. Return
AUM
$12.7B
AUM Growth
+$168M
Cap. Flow
+$367M
Cap. Flow %
2.89%
Top 10 Hldgs %
47.08%
Holding
1,124
New
92
Increased
262
Reduced
503
Closed
191

Sector Composition

Rank Sector Weight
1 Financials 4.72%
2 Technology 3.27%
3 Consumer Discretionary 1.58%
4 Communication Services 1.27%
5 Healthcare 0.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPWH icon
901
Sportsman's Warehouse
SPWH
$43.7M
$70.4K ﹤0.01%
+49,939
New +$67.4K
WRAP icon
902
Wrap Technologies
WRAP
$94.8M
$69K ﹤0.01%
44,834
FLL icon
903
Full House Resorts
FLL
$84.5M
$67.5K ﹤0.01%
30,000
KOPN icon
904
Kopin
KOPN
$663M
$64.7K ﹤0.01%
28,741
STXS icon
905
Stereotaxis
STXS
$129M
$58K ﹤0.01%
+31,500
New +$69K
FISK
906
Empire State Realty OP LP Series 250
FISK
$53.3K ﹤0.01%
+12,067
New +$69.6K
MRCC
907
DELISTED
Monroe Capital Corp
MRCC
$53.3K ﹤0.01%
+11,586
New +$66.9K
GAME icon
908
GameSquare
GAME
$36.8M
$49K ﹤0.01%
181,633
+32
+0% +$11
ANVS icon
909
Annovis Bio
ANVS
$70.6M
$44.6K ﹤0.01%
20,000
VNRX icon
910
VolitionRx Ltd
VNRX
$12M
$44.4K ﹤0.01%
+11,000
New +$52.5K
SSP icon
911
E.W. Scripps
SSP
$274M
$41.1K ﹤0.01%
11,060
-118
-1% -$436
ELME
912
Elme Communities
ELME
$132M
$38.9K ﹤0.01%
+19,364
New +$63.8K
RXRX icon
913
Recursion Pharmaceuticals
RXRX
$1.57B
$38.5K ﹤0.01%
12,535
-300
-2% -$1.16K
GANX icon
914
Gain Therapeutics
GANX
$74.6M
$32.8K ﹤0.01%
16,900
DDD icon
915
3D Systems Corp
DDD
$420M
$30.1K ﹤0.01%
+16,000
New +$35.5K
BYND icon
916
Beyond Meat
BYND
$288M
$28.1K ﹤0.01%
40,018
+20,003
+100% +$16K
OGI
917
Organigram Holdings
OGI
$132M
$24.8K ﹤0.01%
+18,522
New +$27.5K
IVVD icon
918
Invivyd
IVVD
$180M
$22.9K ﹤0.01%
+17,595
New +$32.3K
CRDL
919
Cardiol Therapeutics
CRDL
$136M
$20.5K ﹤0.01%
15,151
CBUS icon
920
Cibus
CBUS
$130M
$19.8K ﹤0.01%
+10,000
New +$25.8K
MIST icon
921
Milestone Pharmaceuticals
MIST
$144M
$12.6K ﹤0.01%
+10,629
New +$18.6K
FEMY icon
922
Femasys
FEMY
$11.2M
$11.8K ﹤0.01%
1,407
GUTS icon
923
Fractyl Health
GUTS
$123M
$7.15K ﹤0.01%
+15,617
New +$14.4K
UP icon
924
Wheels Up
UP
$220M
$5.33K ﹤0.01%
+516
New +$6.73K
GAB.RT
925
DELISTED
The Gabelli Equity Trust Rights (expiring April 14 2026)
GAB.RT
$1.03K ﹤0.01%
+147,080
New +$1.47K

Similar funds

Wealthspire Advisors (New York)'s Q1 2026 Portfolio in Review

As of Q1 2026, Wealthspire Advisors (New York) held 1,124 positions worth $12.7B, up 1.3% from $12.6B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Wealthspire Advisors (New York)'s Q1 2026 filing shows 92 new, 262 increased, 503 reduced and 191 closed positions. Its largest new stake was Beazer Homes USA: 1,117,138 shares worth $21.5M. The largest sale was Alphabet (Google) Class C, an estimated $27.4M.

By sector, the portfolio is most concentrated in Financials at 4.7% of assets, up from 3.2% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Wealthspire Advisors (New York)'s largest Q1 2026 buy was Beazer Homes USA: 1,117,138 shares worth $21.5M.
  • Wealthspire Advisors (New York) added most to Aon in Q1 2026, an estimated $236M increase.
  • Wealthspire Advisors (New York)'s biggest Q1 2026 reduction was Alphabet (Google) Class C, cutting an estimated $27.4M.
  • Wealthspire Advisors (New York) fully exited Huntington Bancshares in Q1 2026, selling an estimated $6.49M.
  • Wealthspire Advisors (New York)'s ten largest holdings make up 47% of its $12.7B portfolio in Q1 2026.
  • Wealthspire Advisors (New York) opened 92 new positions and closed 191 in Q1 2026.
  • Wealthspire Advisors (New York)'s portfolio value rose 1.3% quarter-over-quarter to $12.7B.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.